Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis-Reference-Cited by-同舟云学术

Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis

Published:2019-03-08 Issue:3 Volume:46 Page:2761-2769
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Sychev Dmitry Alekseevich,Abdullaev Sherzod Pardaboevich^ORCID,Mirzaev Karin Badavievich,Ryzhikova Kristina Anatolevna,Shuyev Grigoriy Nikolaevich,Sozaeva Zhannet Alimovna,Grishina Elena Anatolevna,Mammaev Suleiman Nurattinovich,Gafurov Daniyal Musaevich,Kitaeva Elena Yurievna,Shprakh Vladimir Viktorovich,Suleymanov Salavat Sheikhovich,Bolieva Laura Zelimkhanovna,Sozaeva Maryam Sultan-Hamitovna,Zhuchkova Svetlana Mikhailovna,Gimaldinova Natalia Evgenievna,Sidukova Elena Eduardovna,Asoskova Anastasiia Valerievna,Mumladze Robert Borisovich

Funder

OOO Boehringer Ingelheim (Moscow, Russian Federation).

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11033-019-04722-w.pdf

Reference44 articles.

1. Alwan A (2011) Global status report on noncommunicable diseases 2010 Introduction. In: A. Alwan, editor. Global status report on noncommunicable diseases 2010. World Health Organization, Geneva. pp VII–IX. https://www.who.int/nmh/publications/ncd_report2010/en/ . Accessed 26 Aug 2018

2. World Health Organization website. http://www.who.int/cardiovascular_diseases/ru . Accessed 26 Aug 2018

3. Goldhaber SZ, Bounameaux H (2012) Pulmonary embolism and deep vein thrombosis. Lancet 379(9828):1835–1846. https://doi.org/10.1016/S0140-6736(11)61904-1

4. Napalkov DA, Sokolova AA, Rodionov AV (2016) Atrial fibrillation and ischemic heart disease: how to combine antiplatelet and anticoagulant therapy, depending on the clinical situation? Ration Pharmacother Cardiol 2(21):191–195. https://doi.org/10.20996/1819-6446-2016-12-2-191-195 (In Russ)

5. Kirchhof P, Benussi S, Kotecha D et al (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg 50(5):1–88. https://doi.org/10.1093/ejcts/ezw313

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hospital consumption of direct oral anticoagulants in regions of the Russian Federation in 2017–2022;Pharmacy & Pharmacology;2024-01-30

2. The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation;BMC Cardiovascular Disorders;2022-11-11

3. Association between CES1 rs2244613 and the pharmacokinetics and safety of dabigatran: Meta-analysis and quantitative trait loci analysis;Frontiers in Cardiovascular Medicine;2022-08-04

4. Personalizing Direct Oral Anticoagulant Therapy for a Diverse Population: Role of Race, Kidney Function, Drug Interactions, and Pharmacogenetics;Clinical Pharmacology & Therapeutics;2022-08-04

5. CYP2C8, PTGS-1, 2 gene polymorphisms prevalence associated with sensitivity to non-steroidal anti-inflammatory drugs among North Caucasus ethnic groups;Terapevticheskii arkhiv;2021-11-15